榴莲视频

Also in TTHealthWatch: HIV-positive kidney donors

Fatty acid synthase inhibitor targets main drivers of liver injury

Limited benefit seen in patients with established cirrhosis, however

Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS

Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis

Clinicians should perform liver blood tests before and during Veozah treatment

Agency advisory panel to examine complicated efficacy data and liver safety concerns

This difference is mostly explained by their smaller stature, researchers say

Patients who lacked a follow-up visit may be at particularly high risk for death

Also in TTHealthWatch: suicidality among spouses of people with cancer

No difference from placebo in transfusion rate, blood loss, with higher complication rate

Seladelpar improved biochemical response, ALP normalization versus placebo in phase III trial

And liver injuries tied to herbal and dietary supplements are on the rise, data show